Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Washer 

WAVE Life Sciences Ltd diskutieren

WAVE Life Sciences Ltd

WKN: A1436W / Symbol: WVE / Name: WAVE Life / Aktie / Biotechnologie & medizinische Forschung / Small Cap /

14,00 €
-7,28 %

Einschätzung Buy
Rendite (%) -51,11 %
Kursziel 20,25
Veränderung
Endet am 16.10.25

Wave Life Sciences Ltd. (NASDAQ: WVE) was upgraded by analysts at Raymond James from an "outperform" rating to a "strong-buy" rating. They now have a $22.00 price target on the stock, up previously from $13.00.
Ratings data for WVE provided by MarketBeat

Einschätzung Buy
Rendite (%) -52,52 %
Kursziel 20,28
Veränderung
Endet am 17.10.25

Wave Life Sciences Ltd. (NASDAQ: WVE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $22.00 price target on the stock.
Ratings data for WVE provided by MarketBeat

Einschätzung Buy
Rendite (%) -52,86 %
Kursziel 15,71
Veränderung
Endet am 17.10.25

Wave Life Sciences Ltd. (NASDAQ: WVE) had its price target raised by analysts at JPMorgan Chase & Co. from $13.00 to $17.00. They now have an "overweight" rating on the stock.
Ratings data for WVE provided by MarketBeat

Einschätzung Buy
Rendite (%) -38,89 %
Kursziel 20,24
Veränderung
Endet am 31.10.25

Wave Life Sciences Ltd. (NASDAQ: WVE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $22.00 price target on the stock.
Ratings data for WVE provided by MarketBeat

Einschätzung Buy
Rendite (%) -46,88 %
Kursziel 20,21
Veränderung
Endet am 04.11.25

Wave Life Sciences Ltd. (NASDAQ: WVE) had its price target raised by analysts at B. Riley from $19.00 to $22.00. They now have a "buy" rating on the stock.
Ratings data for WVE provided by MarketBeat

Einschätzung Buy
Rendite (%) -58,05 %
Kursziel 33,91
Veränderung
Endet am 12.11.25

Wave Life Sciences Ltd. (NASDAQ: WVE) had its price target raised by analysts at Truist Financial Co. from $17.00 to $36.00. They now have a "buy" rating on the stock.
Ratings data for WVE provided by MarketBeat

Einschätzung Buy
Rendite (%) -62,67 %
Kursziel 20,81
Veränderung
Endet am 13.11.25

Wave Life Sciences Ltd. (NASDAQ: WVE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $22.00 price target on the stock.
Ratings data for WVE provided by MarketBeat

Einschätzung Buy
Rendite (%) -56,79 %
Kursziel 20,88
Veränderung
Endet am 21.11.25

Wave Life Sciences Ltd. (NASDAQ: WVE) had its price target raised by analysts at Mizuho from $19.00 to $22.00. They now have an "outperform" rating on the stock.
Ratings data for WVE provided by MarketBeat

Einschätzung Buy
Rendite (%) 42,86 %
Kursziel 24,76
Veränderung
Endet am 25.02.26

Wave Life Sciences Ltd. (NASDAQ: WVE) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $26.00 price target on the stock.
Ratings data for WVE provided by MarketBeat

Einschätzung Buy
Rendite (%) 36,89 %
Kursziel 20,52
Veränderung
Endet am 05.03.26

Wave Life Sciences Ltd. (NASDAQ: WVE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $22.00 price target on the stock.
Ratings data for WVE provided by MarketBeat

Einschätzung Buy
Rendite (%) 50,80 %
Kursziel 20,39
Veränderung
Endet am 26.03.26

Wave Life Sciences Ltd. (NASDAQ: WVE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $22.00 price target on the stock.
Ratings data for WVE provided by MarketBeat

Einschätzung Buy
Rendite (%) 166,04 %
Kursziel 16,43
Veränderung
Endet am 08.04.26

Wave Life Sciences Ltd. (NASDAQ: WVE) is now covered by analysts at Wedbush. They set an "outperform" rating and a $18.00 price target on the stock.
Ratings data for WVE provided by MarketBeat

Einschätzung Buy
Rendite (%) 118,60 %
Kursziel 8,78
Veränderung
Endet am 29.04.26

Wave Life Sciences Ltd. (NASDAQ: WVE) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $10.00 price target on the stock.
Ratings data for WVE provided by MarketBeat

Wave Life Sciences Ltd. (NASDAQ: WVE) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for WVE provided by MarketBeat

Einschätzung Buy
Rendite (%) 124,00 %
Kursziel 12,27
Veränderung
Endet am 11.06.26

Wave Life Sciences Ltd. (NASDAQ: WVE) is now covered by analysts at Raymond James. They set an "outperform" rating and a $14.00 price target on the stock.
Ratings data for WVE provided by MarketBeat

Einschätzung Buy
Rendite (%) 145,22 %
Kursziel 15,65
Veränderung
Endet am 23.06.26

WAVE Life Sciences Ltd. (NASDAQ: WVE) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $18.00 price target on the stock.
Ratings data for WVE provided by MarketBeat

Einschätzung Buy
Rendite (%) 107,41 %
Kursziel 13,78
Veränderung
Endet am 16.07.26

WAVE Life Sciences Ltd. (NASDAQ: WVE) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $16.00 price target on the stock.
Ratings data for WVE provided by MarketBeat

Einschätzung Buy
Rendite (%) 101,43 %
Kursziel 18,37
Veränderung
Endet am 31.07.26

WAVE Life Sciences Ltd. (NASDAQ: WVE) had its price target lowered by analysts at Wells Fargo & Company from $24.00 to $21.00. They now have an "overweight" rating on the stock.
Ratings data for WVE provided by MarketBeat

Einschätzung Buy
Rendite (%) 105,84 %
Kursziel 18,91
Veränderung
Endet am 03.09.26

WAVE Life Sciences (NASDAQ:WVE) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $22.00 price target on the stock.
Ratings data for WVE provided by MarketBeat

Einschätzung Buy
Rendite (%) 112,12 %
Kursziel 15,44
Veränderung
Endet am 20.10.26

WAVE Life Sciences (NASDAQ:WVE) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $18.00 price target on the stock.
Ratings data for WVE provided by MarketBeat